LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 20 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,880 | +524.5% | 4,295 | +724.4% | 0.00% | – |
| Q2 2023 | $3,824 | +31766.7% | 521 | -82.8% | 0.00% | – |
| Q1 2023 | $12 | +33.3% | 3,037 | +8.4% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 2,801 | -15.3% | 0.00% | – |
| Q3 2022 | $13,000 | +30.0% | 3,306 | +5.1% | 0.00% | – |
| Q2 2022 | $10,000 | +900.0% | 3,146 | +1279.8% | 0.00% | – |
| Q1 2022 | $1,000 | -92.3% | 228 | -91.8% | 0.00% | – |
| Q4 2021 | $13,000 | +116.7% | 2,786 | +270.5% | 0.00% | – |
| Q3 2021 | $6,000 | – | 752 | +1878.9% | 0.00% | – |
| Q2 2021 | $0 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |